Comment on the FDA’s Notice Regarding Quantitative Research on Front of Package Labeling
As FDA finalizes a protocol for its experimental, quantitative study, the agency should develop research objectives that precisely pair with the agency’s policy objectives.
The undersigned organizations and individuals support FDA’s pursuit of research to help select a front-of-package (FOP) labeling scheme that will assist the U.S. population in making informed, healthy food choices. We believe it is critical that FDA conduct this research expeditiously so that consumers can promptly reap the benefits of interpretive FOP labels.